These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3997202)

  • 1. Strain differences in lung granuloma formation in response to a BCG cell-wall vaccine in mice. Demonstration of two types of low responders.
    Kakinuma M; Yamamoto K
    Immunology; 1985 May; 55(1):91-5. PubMed ID: 3997202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of C3H mice to develop lung granuloma after intravenous injection of BCG cell wall vaccine. Demonstration of a defect in lymphoid cells.
    Kakinuma M; Onoé K; Okada M; Kimura T; Kato K; Okuyama H; Morikawa K; Yamamoto K
    Immunology; 1981 May; 43(1):1-9. PubMed ID: 6972900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strain differences in lung granuloma formation in response to a BCG cell-wall vaccine in mice. Failure of antigen presentation by low-responder macrophages.
    Kakinuma M; Onoé K; Yasumizu R; Yamamoto K
    Immunology; 1983 Nov; 50(3):423-31. PubMed ID: 6354921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular regulation of lung granuloma formation and delayed- type hypersensitivity induced with BCG cell walls. Further evidence of involvement of cellular immunity in lung granuloma formation.
    Yamamoto K; Kato K; Kakinuma M; Brehmer W
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Mar; 251(3):357-68. PubMed ID: 7043952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic control of granuloma response to oil-associated BCG cell wall vaccine in mice.
    Yamamoto K; Karinuma M
    Microbiol Immunol; 1978; 22(6):335-48. PubMed ID: 357935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. H-2 I region restriction phenomenon in T cell-dependent granuloma formation to Mycobacterium bovis BCG.
    Ueda K; Yamazaki S; Yamamoto S
    J Reticuloendothel Soc; 1983 Dec; 34(6):475-84. PubMed ID: 6418887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cellular mechanism in the immune response].
    Ohara T; Yamamoto K; Kakinuma M
    Hokkaido Igaku Zasshi; 1979 Jan; 54(1):1-13. PubMed ID: 112017
    [No Abstract]   [Full Text] [Related]  

  • 8. Parallelism between superoxide production of peritoneal exudate cells and lung granulomatous response in mice vaccinated with BCG cell walls.
    Kimura T; Sasaki A; Kato K; Kakinuma M; Yamamoto K
    Immunobiology; 1986 Oct; 173(1):12-22. PubMed ID: 3026956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal boost with adjuvanted heat-killed BCG or arabinomannan-protein conjugate improves primary BCG-induced protection in C57BL/6 mice.
    Haile M; Hamasur B; Jaxmar T; Gavier-Widen D; Chambers MA; Sanchez B; Schröder U; Källenius G; Svenson SB; Pawlowski A
    Tuberculosis (Edinb); 2005; 85(1-2):107-14. PubMed ID: 15687034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of BCG cell wall-induced delayed-type hypersensitivity by BCG pre-treatment. II. Induction of suppressor T cells by heat-killed BCG injection.
    Kato K; Yamamoto K
    Immunology; 1982 Apr; 45(4):655-61. PubMed ID: 6175566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Spleen reactivity after BCG treatement: test and strain dependency of the response].
    Florentin I; Orbach-Arbouys S
    Ann Immunol (Paris); 1977; 128(1-2):271-2. PubMed ID: 15497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal bacille Calmette-Guerin (BCG) vaccine dosage needs balancing between protection and lung pathology.
    Tree JA; Williams A; Clark S; Hall G; Marsh PD; Ivanyi J
    Clin Exp Immunol; 2004 Dec; 138(3):405-9. PubMed ID: 15544615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization with heat-killed Mycobacterium bovis bacille Calmette-Guerin (BCG) in Eurocine L3 adjuvant protects against tuberculosis.
    Haile M; Schröder U; Hamasur B; Pawlowski A; Jaxmar T; Källenius G; Svenson SB
    Vaccine; 2004 Mar; 22(11-12):1498-508. PubMed ID: 15063575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conversion of low antibody responders into high responders by up-regulating the T cell response to a selective epitope.
    Mikszta JA; Kim BS
    J Immunol; 1996 Oct; 157(7):2883-90. PubMed ID: 8816393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal vaccination with Mycobacterium bovis BCG: potential effects as a priming agent shown in a heterologous prime-boost immunization protocol.
    Rahman MJ; Fernández C
    Vaccine; 2009 Jun; 27(30):4038-46. PubMed ID: 19379788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strain variation in BCG-induced chronic pulmonary inflammation in mice: control by a cyclophosphamide-sensitive thymus-derived suppressor cell.
    Moore VL; Mondloch VM; Pedersen GM; Schrier DJ; Allen EM
    J Immunol; 1981 Jul; 127(1):339-42. PubMed ID: 6453897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nature of murine immune response to nucleic acids.
    Fuchs S; Mozes E; Stollar BD
    J Immunol; 1975 Apr; 114(4):1287-91. PubMed ID: 1117141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.
    Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K
    Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of anti-tuberculous protection to lung granuloma produced by intravenous injection of synthetic 6-O-mycoloyl-N-acetylmuramyl-L-alanyl-D-isoglutamine with or without specific antigens.
    Yamamoto K; Kakinuma M; Kato K; Okuyama H; Azuma I
    Immunology; 1980 Aug; 40(4):557-64. PubMed ID: 7000685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic effect of BCG cell-wall skeleton on the tumor induction by 7,12-dimethylbenz[a]anthracene in mice: strain difference.
    Ikegami R; Takatsu K; Ono S; Hamaoka T; Fujiwara H; Kitagawa M; Azuma I; Yamamura Y
    Gan; 1979 Feb; 70(1):101-7. PubMed ID: 109342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.